Guidant

      FDA Failures Continue to Put Patients at Risk

      April 5th, 2012

      5 Apr – In 1957, the Upjohn Company launched the antibiotic Panalba.  The drug was administered to thousands of Americans for more than a decade.  By 1968, Panalba sales totaled $18 million.  After years of complaints related to the drug, FDA Commissioner Herbert Ley Jr., reported that (more…)

      AT ISSUE

      OMSJ Demands Editors to Depublish Gallo's Reports

      TAKE ACTION

      KEY ISSUES

        MORE